Thomson Medical Group Limited (FRA:3H5)
Germany · Delayed Price · Currency is EUR 0.0380
0.00 (0.00%)
At close: Feb 20, 2026
Thomson Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 408.67 | 394.66 | 351.15 | 355.77 | 333.71 | 240.4 |
Other Revenue | 60.86 | 60.87 | 31.5 | 4.79 | 4.79 | - |
Revenue | 469.53 | 455.53 | 382.65 | 360.56 | 338.5 | 240.4 |
Revenue Growth (YoY) | 13.56% | 19.04% | 6.13% | 6.52% | 40.81% | 11.23% |
Cost of Revenue | 248.83 | 234.82 | 197.52 | 177.35 | 163.24 | 124.38 |
Gross Profit | 220.7 | 220.71 | 185.14 | 183.21 | 175.26 | 116.02 |
Other Operating Expenses | 166.33 | 166.12 | 83.24 | 79.88 | 65.52 | 49.25 |
Operating Expenses | 206.77 | 204.8 | 111.61 | 100.95 | 83.45 | 67.2 |
Operating Income | 13.92 | 15.91 | 73.52 | 82.26 | 91.81 | 48.81 |
Interest Expense | -53.96 | -59.66 | -51.55 | -30.51 | -23.5 | -23.61 |
Interest & Investment Income | 2.55 | 3.62 | 7.38 | 3.95 | 0.99 | 0.98 |
Earnings From Equity Investments | -0.01 | -0.48 | -0.19 | -0.49 | - | - |
EBT Excluding Unusual Items | -37.5 | -40.62 | 29.16 | 55.2 | 69.3 | 26.18 |
Pretax Income | -37.5 | -40.62 | 29.16 | 55.2 | 69.3 | 26.18 |
Income Tax Expense | 6 | 6.36 | 10.94 | 14.15 | 10.71 | 9.27 |
Earnings From Continuing Operations | -43.5 | -46.98 | 18.21 | 41.06 | 58.59 | 16.91 |
Net Income to Company | -43.5 | -46.98 | 18.21 | 41.06 | 58.59 | 16.91 |
Minority Interest in Earnings | -1.43 | -0.6 | -4.06 | -4.5 | -4.82 | -2.67 |
Net Income | -44.92 | -47.58 | 14.16 | 36.56 | 53.76 | 14.24 |
Net Income to Common | -44.92 | -47.58 | 14.16 | 36.56 | 53.76 | 14.24 |
Net Income Growth | - | - | -61.27% | -32.01% | 277.62% | - |
Shares Outstanding (Basic) | 26,441 | 26,441 | 26,441 | 26,441 | 26,441 | 26,441 |
Shares Outstanding (Diluted) | 26,441 | 26,459 | 26,459 | 26,447 | 26,441 | 26,441 |
Shares Change (YoY) | - | - | 0.05% | 0.02% | - | - |
EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Growth | - | - | -61.20% | -32.04% | 277.14% | - |
Free Cash Flow | 45.56 | 37.87 | 56.49 | 77.39 | 65.05 | 23.96 |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share | - | - | - | 0.000 | - | - |
Gross Margin | 47.00% | 48.45% | 48.38% | 50.81% | 51.78% | 48.26% |
Operating Margin | 2.96% | 3.49% | 19.21% | 22.81% | 27.12% | 20.30% |
Profit Margin | -9.57% | -10.44% | 3.70% | 10.14% | 15.88% | 5.92% |
Free Cash Flow Margin | 9.70% | 8.31% | 14.76% | 21.46% | 19.22% | 9.97% |
EBITDA | 39.19 | 41.73 | 94.14 | 95.42 | 102.95 | 59.54 |
EBITDA Margin | 8.35% | 9.16% | 24.60% | 26.46% | 30.41% | 24.77% |
D&A For EBITDA | 25.27 | 25.82 | 20.61 | 13.16 | 11.14 | 10.73 |
EBIT | 13.92 | 15.91 | 73.52 | 82.26 | 91.81 | 48.81 |
EBIT Margin | 2.96% | 3.49% | 19.21% | 22.81% | 27.12% | 20.30% |
Effective Tax Rate | - | - | 37.53% | 25.63% | 15.46% | 35.41% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.